Question-filled future for dose-escalation in prostate cancer

被引：0
|
作者：
机构：
来源：
Int J Radiat Oncol Biol Phys | / 3卷 / 891期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
    Onaga, Ryutaro
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Tanaka, Nobukazu
    Hoshi, Yuta
    Kishida, Takuma
    Tanaka, Hideki
    Sato, Masanobu
    Takeshita, Naohiro
    Kuboki, Ryo
    Nishino, Hiroshi
    Ito, Makoto
    Tahara, Makoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (10) : 1435 - 1443
  • [42] Definite chemo-radiotherapy with dose-escalation to patients with esophageal cancer
    Nielsen, M.
    Holtved, E.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S562 - S563
  • [43] PRELIMINARY-RESULTS OF A HYPERFRACTIONATED DOSE-ESCALATION STUDY FOR LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE
    FORMAN, JD
    ORTON, C
    EZZELL, G
    PORTER, AT
    RADIOTHERAPY AND ONCOLOGY, 1993, 27 (03) : 203 - 208
  • [44] Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    Kuban, Deborah A.
    Tucker, Susan L.
    Dong, Lei
    Starkschall, George
    Huang, Eugene E.
    Cheung, M. Rex
    Lee, Andrew K.
    Pollack, Alan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01): : 67 - 74
  • [45] Acute and Late toxicity of Dose-escalation Intensity Modulated Arc Therapy (RapidArc) for Prostate cancer to 82.8 Gy: an Update
    Hentschel, B.
    Strauss, D.
    Wagner, K.
    Dorn, U.
    Oehler, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 72 - 72
  • [46] Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study
    Alayed, Yasir
    Loblaw, Andrew
    Chu, William
    Al-Hanaqta, Motasem
    Chiang, Andrew
    Jain, Suneil
    Chung, Hans
    Vesprini, Danny
    Morton, Gerard
    Ravi, Ananth
    Davidson, Melanie
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Erler, Darby
    Cheung, Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1066 - 1073
  • [47] Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
    Hou, Wei-Hsien
    Huang, Chao-Yuan
    Wang, Chia-Chun
    Lan, Keng-Hsueh
    Chen, Chung-Hsin
    Yu, Hong-Jen
    Liu, Shih-Ping
    Lai, Ming-Kuen
    Pu, Yeong-Shau
    Cheng, Jason Chia-Hsien
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (05) : 596 - 601
  • [48] Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
    Hummel, Horst-Dieter
    Kufer, Peter
    Gruellich, Carsten
    Seggewiss-Bernhardt, Ruth
    Deschler-Baier, Barbara
    Chatterjee, Manik
    Goebeler, Maria-Elisabeth
    Miller, Kurt
    de Santis, Maria
    Loidl, Wolfgang
    Dittrich, Christian
    Buck, Andreas
    Lapa, Constantin
    Thurner, Annette
    Wittemer-Rump, Sabine
    Koca, Gokben
    Boix, Oliver
    Doecke, Wolf-Dietrich
    Finnern, Ricarda
    Kusi, Helena
    Ajavon-Hartmann, Antoinette
    Stienen, Sabine
    Sayehli, Cyrus Michael
    Polat, Buelent
    Bargou, Ralf C.
    IMMUNOTHERAPY, 2021, 13 (02) : 125 - 141
  • [49] Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath® technique
    Fransson, P
    Löfroth, PO
    Franzén, L
    Henriksson, R
    Bergström, P
    Widmark, A
    ACTA ONCOLOGICA, 2001, 40 (06) : 756 - 765
  • [50] A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
    Kainuma, Takuro
    Kawakami, Shogo
    Tsumura, Hideyasu
    Satoh, Takefumi
    Tabata, Ken-ichi
    Iwamura, Masatsugu
    Hayakawa, Kazushige
    Ishiyama, Hiromichi
    RADIATION ONCOLOGY, 2019, 14 (01)
12345